Publications by authors named "Liora Schultz"

Claim this Profile
C
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Hrishikesh K Srinagesh, Anne Marijn Kramer, John H Baird, Agnes Reschke, Bita Sahaf, Liora M Schultz

Blood Cancer Discov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statement.
Adam Lamble, Sandra D Bohling, Kara L Davis, Aimee C Talleur, Kevin O McNerney, Liora Schultz

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.
Swati Naik, Subodh Selukar, Aimee C Talleur, Samira Deshpande, Gabriela Llaurador Caraballo, Liora Michal Schultz

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LocaTIAN, locaTIAN, locaTIAN.
Juliane Gust, Liora M Schultz

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.
Alexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, Hao-Wei Wang, Bita Sahaf, Liora Michal Schultz

Cytotherapy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain MRI changes in children and young adults with B-cell acute lymphoblastic leukemia following chimeric antigen receptor T-cell therapy.
Hyun Gi Kim, Kristen W Yeom, Iryna Vasyliv, Zahra Shokri Varniab, Courtney Erickson, Liora Michal Schultz

Eur Radiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel.
Lauren Elizabeth Appell, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly L Pacenta, Liora M Schultz

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers.
Kevin O McNerney, Caroline Diorio, Colleen Annesley, Rebecca A Gardner, Andrea K Graham, Liora M Schultz

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CAR T cell therapy on thymus size in children and young adults with acute lymphoblastic leukemia.
Iryna Vasyliv, Hyun Gi Kim, Courtney Erickson, Christina Baggott, Liora Michal Schultz

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel in Practice: Real-World Lessons in Pediatric and Young Adult B-ALL.
Kevin O McNerney, Liora M Schultz

Transplant Cell Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy.
Hannah Lust, Liora M Schultz, Soyang Kwon, Gregory W Roloff, Ibrahim Aldoss

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to CARe: A Narrative of Real-World Medical Decision-Making to Access Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children, Adolescents, and Young Adults.
Angela Steineck, Karen Chao, Anurekha G Hall, Elad Jacoby, Allison Barz Leahy, Liora M Schultz

Pediatr Blood Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.
Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers, Liora M Schultz

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking in the Rearview as We Drive CARs Forward.
Liora M Schultz

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz

Nature· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen W Yeom, Liora M Schultz

Nature· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy.
Claire Johns, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Liora Schultz

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.
Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner, Liora M Schultz

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults.
Adam J Lamble, Liora M Schultz, Khanh Nguyen, Emily M Hsieh, Kevin McNerney

Blood Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.
Michelle Monje, Jasia Mahdi, Robbie Majzner, Kristen Yeom, Liora M Schultz

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Liora M Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh

Leukemia· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.
John A Ligon, Sneha Ramakrishna, Francesco Ceppi, Friso G J Calkoen, Caroline Diorio, Liora M Schultz

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediport use as an acceptable standard for CAR T cell infusion.
Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J M King, Dhruv Bhatt, Liora M Schultz

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
Kevin O McNerney, Amy Moskop, Lena E Winestone, Christina Baggott, Julie-An Talano, Liora Schultz

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen, Liora M Schultz

EClinicalMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis